Literature DB >> 15605591

Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices.

F Veiga1, T Salsa, M E Pina.   

Abstract

Part I of this article reported general considerations of oral controlled release dosage forms and the applications of cellulose ether polymers in hydrophilic matrices. Part II of this study describes the advantages and disadvantages of limited swelling hydrophilic matrices, their preparation, mechanism, and parameters affecting drug release from these systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 15605591     DOI: 10.3109/03639049809082346

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  5 in total

Review 1.  Controlled release systems containing solid dispersions: strategies and mechanisms.

Authors:  Phuong Ha-Lien Tran; Thao Truong-Dinh Tran; Jun Bom Park; Beom-Jin Lee
Journal:  Pharm Res       Date:  2011-05-07       Impact factor: 4.200

2.  Deep depth profiling using gas cluster secondary ion mass spectrometry: Micrometer topography development and effects on depth resolution.

Authors:  Shin Muramoto; Dan Graham
Journal:  Surf Interface Anal       Date:  2021-07-06       Impact factor: 1.702

Review 3.  Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.

Authors:  Kaushika Patel; Shreeraj Shah; Jaymin Patel
Journal:  Daru       Date:  2022-04-18       Impact factor: 4.088

4.  Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of in-vivo plasma profiles.

Authors:  Soha M El-Masry; Sally A Helmy
Journal:  Saudi Pharm J       Date:  2020-11-06       Impact factor: 4.330

5.  Long-Term Polygraphic Monitoring through MEMS and Charge Transfer for Low-Power Wearable Applications.

Authors:  Alessandro Manoni; Alessandro Gumiero; Alessandro Zampogna; Chiara Ciarlo; Lorenzo Panetta; Antonio Suppa; Luigi Della Torre; Fernanda Irrera
Journal:  Sensors (Basel)       Date:  2022-03-27       Impact factor: 3.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.